2015∼2020년 동안 인천 지역 단일기관에서의 비결핵항산균 분포 및 항균제 내성률
Distribution and Antimicrobial Resistance of Non-Tuberculous Mycobacteria during 2015∼2020: A Single-Center Study in Incheon, South Korea
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
본 연구는 인천지역에 위치한 단일기관의 비결핵항산균의 분포 및 항균제 내성률과 동반 세균 빈도를 조사한 것으로, 2015 년부터 2020년까지 TB/NTM real-time PCR 검사가 의뢰된8,258건의 환자 데이터를 후향적으로 검토하였다. 총 296건의검체가 NTM 양성이었고, 발생률은 2015년 2.5% (30/1,209) 에서 2020년 3.8% (66/1,740)로 증가하였다. NTM으로 확인된 296건 중, 54.7% (162/296)는 M. avium complex (MAC)에 속하는 균종으로 확인되었고, 그다음으로 M. abscessus complex (MABC) 20.9% (62/296), M. fortuitum 6.4% (19/296) 및 M. flavescens 3.4% (10/296) 순이었다. NTM 양성 검체 중, 약제내성검사가 의뢰된 검체는 76.7% (227/296) 였다. 다제내성 NTM은 40.1% (91/227)였고, 광범위 내성NTM은 59.9% (136/227)였다. NTM과 동시 감염은 43.4% (63/145)이었고 가장 흔한 균종은 Klebsiella pneumonia (23.8%, 15/63)였다. 본 연구는 인천지역의 NTM 분포 및 항균제 내성률과 동반 세균 빈도에 관한 최초 보고이다. NTM 감염의 비율은 점차적으로 증가하는 추세이며 효과적인 관리를 위해적극적인 진료와 철저한 감염관리가 필요할 것이다.
Abstract
This study sought to investigate the distribution, antimicrobial resistance rate, and bacterial co-infection frequency of non-tuberculous mycobacteria (NTM) in a single center in Incheon, South Korea. A total of 8,258 specimens submitted for tuberculosis (TB)/NTM real-time PCR tests during the years 2015 to 2020 were retrospectively reviewed. In total, 296 specimens (3.6%) were NTM positive, and the positivity increased from 2.5% (30/1,209) in 2015 to 3.8% (66/1,740) in 2020. Of 296 NTM specimens, 54.7% (162/296) were identified as the Mycobacterium avium complex (MAC) followed by the Mycobacterium abscessus complex (MABC) 20.9% (62/296), M. fortuitum 6.4% (19/296) and M. flavescens 3.4% (10/296). Of the NTM-positive specimens, 76.7% (227/296) were tested for drug resistance. The results showed multidrug-resistant NTM in 40.1% (91/227) and extensively drug-resistant NTM in 59.9% (136/227) of these specimens. Of the 145 isolates taken for bacterial culture, bacteria/fungi co-infection with NTM accounted for 43.4% (63/145), in which the most common bacterial species was Klebsiella pneumonia (23.8%, 15/63). This study is the first report on the distribution and antimicrobial resistance of NTM in Incheon. As the proportion of NTM infections increases, active treatment and thorough infection control are required for effective management.
참고문헌 (28)
- 박영목, "Age- and sex-related characteristics of the increasing trend of nontuberculous mycobacteria pulmonary disease in a tertiary hospital in South Korea from 2006 to 2016", The Korean Journal of Internal Medicine, 35(6), pp.1424~1431 (2020), 대한내과학회[DOI]
- Olivier KN, "Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis", Am J Respir Crit Care Med, 167, pp.828~834 (2003)[DOI]
- Falkinham JO, "Nontuberculous mycobacteria in the environment", Clin Chest Med, 23, pp.529~551 (2002)[DOI]
- Marras TK, "Epidemiology of human pulmonary infection with non-tuberculous mycobacteria", Clin Chest Med, 23, pp.553~567 (2002)[DOI]
- Sharma SK, "Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases", Indian J Med Res, 152, pp.185~226 (2020)[DOI]
- Global tuberculosis report 2018, "WHO", WHO, ~ (2018)
- 홍경수, "대구지역 한 대학병원에서 비결핵 항산균의 미생물학적 분포 및 임상적 특성", Journal of Yeungnam Medical Science, 32(2), pp.71~79 (2015), 영남대학교 의과대학[DOI]
- 홍성균, "Distribution and Antibiotic Susceptibility Patterns of Genus Mycobacterium at a Private Hospital, Korea", 대한의생명과학회지, 19(2), pp.132~141 (2013), 대한의생명과학회
- Hoefsloot W, "The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples", Eur Respir J, 42, pp.1604~1613 (2013)[DOI]
- Primm TP, "Health impacts of environmental mycobacteria", Clin Microbiol Rev, 17, pp.98~106 (2004)[DOI]
- Seon Cheol Park, "Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study", BMC Pulmonary Medicine, 19(1), pp.140~148 (2019), Springer Science and Business Media LLC[DOI]
- 백해경, "최근 10년간 광주 2차병원의 호흡기검체에서 분리된 비결핵항산균의 폐질환 유병률에 대한 연구", 대한임상검사과학회지, 52(4), pp.349~355 (2020), 대한임상검사과학회[DOI]
- Clinical and Laboratory Standards Institute, "Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes;approved standard", Clinical and Laboratory Standards Institute, M24~M62 (2018)
- Joint Committee for the Revision of Korean Guidelines for Tuberculosis, "Korean Guidelines for Tuberculosis", ~ (2020)
- Huh KM, "Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019(COVID-19)outbreak in Korea : a nationwide surveillance study", Clin Infect Dis, 72, pp.184~191 (2021)[DOI]
- Henkle E, "Population-based incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012", Ann Am Thorac Soc, 12, pp.642~647 (2015)[DOI]
- Daley CL, "Epidemiology of human pulmonary infection with nontuberculous mycobacteria", Clin Chest Med, 23, pp.553~567 (2002)[DOI]
- Sakatani M, "The non-tuberculous mycobacteriosis", Kekkaku, 80, pp.25~30 (2005)
- 김남희, "Recovery Rates of Non-Tuberculous Mycobacteria from Clinical Specimens Are Increasing in Korean Tertiary-Care Hospitals", Journal of Korean Medical Science, 32(8), pp.1263~1267 (2017), 대한의학회
- Jankovic M, "Geographical distribution and clinical relevanceof non-tuberculous mycobacteria in Croatia", Int J Tuberc Lung Dis, 17, pp.836~841 (2013)[DOI]
- Van lugen J, "The changing pattern of clinical Mycobacterium avium isolation in the Netherlands", Int J Tuberc Lung Dis, 14, pp.1176~1180 (2010)
- Panagiotou M, "The epidemiology of pulmonary nontuberculous mycobacteria : data from a general hospital in Athens, Greece, 2007-2013", Pulm Med, 2014, pp.894976~ (2014)[DOI]
- Clinical and Laboratory Standards Institute, "Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes;approved standard", Clinical and Laboratory Standards Institute, M24~ (2018)
- 이승헌, "The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea", Annals of Laboratory Medicine, 34(1), pp.31~37 (2014), 대한진단검사의학회
- Jeon KM, "Antibiotic treatment of Mycobacterium abscessus lung disease : a retrospective analysis of 65 patients", Am J Respir Crit Care Med, 180, pp.896~902 (2009)[DOI]
- Gorsich EE, "Opposite outcomes of coinfection at individual and population scales", PNAS, 115, pp.7545~7550 (2018)[DOI]
- Geurts K, "Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection : bonnie and clyde?", Eur Respir J, 54, pp.1900117~ (2019)[DOI]
- Yong Kwan Lim, "Impact of bacterial and viral coinfection in community-acquired pneumonia in adults", Diagnostic Microbiology and Infectious Disease, 94(1), pp.50~54 (2019), Elsevier BV[DOI]
